Across a seed and Series A round, Healthleap has collected $38 million. Sequoia Capital and First Round Capital co-led the $8 million seed, and Hummingbird Ventures led the $30 million Series A.
The company’s origin was a clinical nutrition tool for dietitians, launched in South Africa in 2022 by siblings. It has grown into a surveillance layer that hooks into hospital electronic health records.
Notes as the signal
Clues that structured fields overlook, among them recent weight loss or trouble swallowing, are pulled from clinicians’ written notes by language models. Combined with labs and vitals, those signals feed a nightly review of every adult inpatient record, and each morning a ranked risk score appears inside the care team’s existing workflow.
Founders Josiah Meyer and Jemima Meyer are siblings; Josiah Meyer is chief executive. He has said the software stops short of diagnosing patients, leaving that judgment to clinicians.
Penn Medicine, Cedars-Sinai and Emory Healthcare are among the more than 50 hospitals using the platform today. Screening began with malnutrition and delirium, and the aim is to reach more than 40 major conditions.
Over the past year revenue climbed more than tenfold, according to the company. Engineering, product, sales and an expansion into outpatient and home care will absorb the new capital.
